These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26017674)

  • 1. Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA.
    Chen JJ; Liu SX; Chen MZ; Zhao ZY
    Mol Med Rep; 2015 Sep; 12(3):3569-3574. PubMed ID: 26017674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
    Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
    Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined application of cisplatin and celecoxib inhibits the proliferation and promotes apoptosis of nasopharyngeal carcinoma cells resistant to cisplatin].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):203-6, 211. PubMed ID: 25652863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
    Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
    Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
    Wang G; Wang S; Li C
    Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
    Wang Y; Cheng N; Luo J
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.
    Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C
    Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity.
    Voon YL; Ahmad M; Wong PF; Husaini R; Ng WT; Leong CO; Lane DP; Khoo AS
    Oncol Rep; 2015 Oct; 34(4):1692-700. PubMed ID: 26252575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
    PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
    World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
    Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
    Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.